HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.

Abstract
FBL-3N is an MHC class II Ag+ variant line that was obtained spontaneously during maintenance of Friend virus-induced leukemia FBL-3 in an athymic C57BL/6 (B6) mouse. Inocula of FBL-3N, but not the parental FBL-3 tumor, regressed after initial growth in CD8-depleted, syngeneic B6 mice. The cellular mechanisms by which FBL-3N was rejected in these mice were investigated in this study. We demonstrated that CTL with both CD4+ and CD4-CD8-TCR-alpha beta phenotypes were generated in mixed lymphocyte tumor cell culture spleen cells obtained from CD8-depleted B6 mice that had rejected FBL-3N by in vitro stimulation with mitomycin C-treated FBL-3N. After adoptive transfer of these CTL that were generated in vitro into athymic B6 mice, challenge with the FBL-3N tumor resulted in tumor regression after its initial growth. Thus, CD4+ and CD4-CD8-TCR-alpha beta CTL mediated rejection of the FBL-3N tumor in CD8-depleted B6 mice. Furthermore, the findings that depletion of B6 mice of CD4+ cells in addition to CD8+ cells abrogated the rejection of FBL-3N and generation of CTL in mixed lymphocyte tumor cell culture spleen cells suggest that CD4+ cells were required not only as a source of CD4+ CTL, but also as helper cells for generation of CD4-CD8-TCR-alpha beta CTL. Tumor Ag recognition of CD4-CD8-TCR-alpha beta CTL was restricted to Db, like that of classical CD8+ CTL, but the restriction appeared to be less obligatory than that of CD8+ CTL.
AuthorsA Yoshimura, H Shiku, E Nakayama
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 150 Issue 11 Pg. 4900-10 (Jun 01 1993) ISSN: 0022-1767 [Print] United States
PMID8496592 (Publication Type: Journal Article)
Chemical References
  • CD4 Antigens
  • CD8 Antigens
  • Histocompatibility Antigens Class II
  • Receptors, Antigen, T-Cell, alpha-beta
Topics
  • Animals
  • Antibody Specificity
  • Binding Sites, Antibody
  • CD4 Antigens (analysis)
  • CD8 Antigens (analysis, physiology)
  • Clone Cells (chemistry)
  • Cytotoxicity, Immunologic
  • Flow Cytometry
  • Friend murine leukemia virus
  • Genetic Variation (immunology)
  • Graft Rejection
  • Histocompatibility Antigens Class II (analysis)
  • Immunotherapy, Adoptive
  • Leukemia, Erythroblastic, Acute (immunology)
  • Lymphocyte Depletion
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Transplantation
  • Receptors, Antigen, T-Cell, alpha-beta (analysis)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: